Product Images Topiramate

The text describes cumulative seizure rates for two different doses of Topiramate (50 mg/day and 400 mg/day) over time. There is a visual representation of this data on a graph with time in days on the x-axis and seizure rates on the y-axis. The graph shows that the higher dose of Topiramate resulted in a lower rate of seizures and the difference was statistically significant with a p-value of 0.0002.*

The text describes the change in the average monthly migraine period rate during a double-blind phase in a study comparing Topiramate at different doses and Placebo. The data is presented in a table and indicates statistical significance (p<0.010 and p<0.001) for some of the treatment groups compared to Placebo.*

This is a label of Topiramate Tablets, USP 200mg which is a generic drug for Topamax. The label warns that transferring the tablets is prohibited by Federal law. The tablets are manufactured by Zydus Pharmaceuticals USA Inc. and each film-coated tablet contains 200mg of topiramate. The rest of the information on the label pertains to lot numbers, expiration dates, and other manufacturing details.*